and Argentine pharma Bagó, with a total investment of 600 million rupees ($7.2 million). Hepatitis affects 7–10% of the Pakistani population, and this manufacturing plant will enable the ...

On December 1, Pfizer became the first big pharma to commit to take to market a late-stage biologic drug produced in plant cells. It acquired rights to taligurase alfa, a form of the enzyme ...

Competition Commission of India (CCI) has approved the proposed combination involving acquisition of pharma solution segment ...

Roughly a year after receiving an FDA reprimand at its manufacturing plant in Michigan, Indian drugmaker Piramal Pharma has landed in the regulator’s crosshairs once again. Following an ...

It will be the first ADC facility at the pharma ... the plant will help AZ achieve its ambition to position ADCs as a replacement for traditional chemotherapies across many different types of ...